Skip to main content
SpringerLink
Log in

Can specific axillary radiotherapy be omitted in undissected, clinically node-negative patients who undergo breast-conserving therapy?

  • Editorial
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Early Breast Cancer Trialists’ Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women.Lancet 1992;339:1–15, 71–85.

    Google Scholar 

  2. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.J Natl Cancer Inst 1997;89:1673–82.

    Article  PubMed  CAS  Google Scholar 

  3. Kissin MW, Querci della Rovere G, Easton D, Westbury G. Risk of lymphoedema following the treatment of breast cancer.Br J Surg 1986;73:580–4.

    PubMed  CAS  Google Scholar 

  4. Larson D, Weinstein M, Goldberg I, et al. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy.Int J Radiat Oncol Biol Phys 1986;12:1575–82.

    PubMed  CAS  Google Scholar 

  5. Yeoh EK, Denham JW, Davies SA, Spittle MF. Primary breast cancer: complications of axillary management.Acta Radiol Oncol 1986;25:105–8.

    PubMed  CAS  Google Scholar 

  6. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.N Engl J Med 1985;312:674–81.

    Article  PubMed  CAS  Google Scholar 

  7. Cabanes PA, Salmon RJ, Vilcoq JR, et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer.Lancet 1992;339:1245–8.

    Article  PubMed  CAS  Google Scholar 

  8. Louis-Sylvestre C, Clough KB, Falcou M-C, et al. A randomized trial comparing axillary dissection and axillary radiotherapy for early breast cancer: 15 year results [Abstract].Breast Cancer Res Treat 2001;69:212.

    Google Scholar 

  9. Halverson KJ, Taylor ME, Perez CA, et al. Regional nodal management and patterns of failure following conservating surgery and radiation therapy for stage I and II breast cancer.Int J Radiat Oncol Biol Phys 1993;26:593–9.

    PubMed  CAS  Google Scholar 

  10. Hoskin PJ, Rajan B, Ebbs S, et al. Selective avoidance of lymphatic radiotherapy in the conservative management of early breast cancer.Radiother Oncol 1992;25:83–8.

    Article  PubMed  CAS  Google Scholar 

  11. Kuznetsova M, Graybill JC, Zusag TW, et al. Omission of axillary lymph node dissection in early-stage breast cancer: effect on treatment outcome.Radiology 1995;197:507–10.

    PubMed  CAS  Google Scholar 

  12. Wong JS, Recht A, Beard CJ, et al. Treatment outcome after tangential radiation therapy without axillary dissection in patients with early-stage breast cancer and clinically-negative axillary nodes.Int J Radiat Oncol Biol Phys 1997;39:915–20.

    Article  PubMed  CAS  Google Scholar 

  13. Martelli G, Moglia D, Boracchi P, et al. Surgical resection plus tamoxifen as treatment of breast cancer in elderly patients: a retrospective study.Eur J Cancer 1993;29A:2080–2.

    Article  PubMed  CAS  Google Scholar 

  14. Baxter N, McCready D, Chapman J, et al. Clinical behavior of untreated axillary nodes after local treatment for primary breast cancer.Ann Surg Oncol 1996;3:235–40.

    Article  PubMed  CAS  Google Scholar 

  15. Zurrida S, Orecchia R, Galimberti V, et al. Axillary radiotherapy instead of axillary dissection: a randomized trial.Ann Surg Oncol 2002;9:156–60.

    Article  PubMed  Google Scholar 

  16. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer: a review.Cancer 1995;76:1491–1512.

    Article  PubMed  CAS  Google Scholar 

  17. Bentel GC, Marks LB, Hardenbergh PH, Prosnitz LR. Variability of the depth of supraclavicular and axillary lymph nodes in patients with breast cancer: is a posterior axillary boost field necessary?Int J Radiat Oncol Biol Phys 2000;47:755–8.

    Article  PubMed  CAS  Google Scholar 

  18. Goodman RL, Grann A, Saracco P, Needham MF. The relationship between radiation fields and regional lymph nodes in carcinoma of the breast.Int J Radiat Oncol Biol Phys 2001;50:99–105.

    Article  PubMed  CAS  Google Scholar 

  19. Aristei C, Chionne F, Marsella AR, et al. Evaluation of level I and II axillary nodes included in the standard breast tangential fields and calculation of the administered dose: results of a prospective study.Int J Radiat Oncol Biol Phys 2001;51:69–73.

    Article  PubMed  CAS  Google Scholar 

  20. Krasin M, McCall A, King S, et al. Evaluation of a standard breast tangent technique: a dose-volume analysis of tangential irradiation using three-dimensional tools.Int J Radiat Oncol Biol Phys 2000; 47:327–33.

    Article  PubMed  CAS  Google Scholar 

  21. Reznik J, Cicchetti MG, DeGaspe B, FitzGerald TJ. Analysis of axillary coverage during tangential radiation therapy to the breast [Abstract].Int J Radiat Oncol Biol Phys 2001;51(Suppl 1):6–7.

    Article  Google Scholar 

  22. Fisher B, Wolmark N, Bauer M, et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast.Surg Gynecol Obstet 1981;152:765–72.

    PubMed  CAS  Google Scholar 

  23. Wong JS, O’Neill A, Recht A, et al. The relationship between lymphatic vessel invasion, tumor size and pathologic nodal status: can we predict who can avoid a third field in the absence of axillary dissection?Int J Radiat Oncol Biol Phys 2000;48:133–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Dana-Farber Cancer, Institute/Brigham and Women’s Hospital, Harvard Medical School, 75 Francis St., 02115, Boston, Massachusetts

    Julia S. Wong MD & Jay R. Harris MD

Authors
  1. Julia S. Wong MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jay R. Harris MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wong, J.S., Harris, J.R. Can specific axillary radiotherapy be omitted in undissected, clinically node-negative patients who undergo breast-conserving therapy?. Annals of Surgical Oncology 9, 117–119 (2002). https://doi.org/10.1007/BF02557361

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02557361

Search

Navigation